Buscar
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030
DMIIRAñadir a la lista de seguimiento
0.081USD
+0.000+0.25%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
0.00Cap. mercado
--P/E TTM
Más Datos de Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 Compañía
Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to search for business combination targets in the pharmaceutical industry. The Company is neither engaged in any operations nor generated any revenues.
Información de Drugs Made In America Acquisition II Rights Exp 16 Sep 2030
Símbolo de cotizaciónDMIIR
Nombre de la empresaDrugs Made In America Acquisition II Corp
Fecha de salida a bolsaSep 25, 2025
Director ejecutivoStockwell (Lynn)
Número de empleados- -
Tipo de seguridadRight
Fin del año fiscal- -
Dirección1 East Broward Boulevard
CiudadFT LAUDERDALE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal33301
Teléfono19548703099
Sitio Web
Símbolo de cotizaciónDMIIR
Fecha de salida a bolsaSep 25, 2025
Director ejecutivoStockwell (Lynn)
Ejecutivos de Drugs Made In America Acquisition II Rights Exp 16 Sep 2030
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Drugs Made In America Acquisition II Rights Exp 16 Sep 2030?
Los cinco principales accionistas de Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 son: Ms. Lynn Stockwell